

Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.
Investor Presentation Deck
Tetra Investor Presentation


Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.
Investor Presentation Deck
Tetra Investor Presentation
– Second Quarter Total Revenue Grows by 24% Year-Over-Year- Second Quarter Highlighted by 249% Increase in Product Revenue- Company to Host Q2 2019 Financial Results Conference Call on Thursday, August 15, 2019, at 4:15 p.m. […]
Cathie Wood, of ARK Genomic Revolution ETF(NYSE: ARKG) explains the multi-trillion dollar opportunity in the Genomics Revolution: CAR-T, CRISPR, and DNA Sequencing Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for […]
Nancy Bush Huber brings over 25 years of executive management roles, primarily as CFO of several publicly traded and private companies- Most recent position was as CFO of consumer packaged goods company for 13 years- […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
